These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-002788-25 Hippocampal volume in young adults with moderate to severe depression before and after combined antidepressant therapy not-yet-due
Completed, report not yet due 2004-002803-34 Phase I/II-Studie Praeoperative Radiochemotherapie mit Capecitabin plus Oxaliplatin und Cetuximab beim lokal fortgeschrittenen Rektumkarzinom im UICC-Stadium II und III 2009-11-01 not-yet-due
Ongoing 2004-004953-24 A double-blind placebo-controlled two period crossover study of pregabalin and aprepitant in the electrical hyperalgesia model of central sensitisation in healthy volunteers not-yet-due
Ongoing 2004-005211-28 A double-blind placebo-controlled four period crossover study of paracetamol and tramadol in the electrical hyperalgesia model of central sensitisation in healthy volunteers not-yet-due
Not reported 2004-005223-18 Evaluation of growth response in short children suffering from a disease with growth retardation and treated with Somatropin: A prospective, longitudinal non-randomised, open, phase II study 2011-02-17 due-trials
Not reported 2005-000570-52 Einfluss von Pioglitazon auf den 24-Stunden-Blutdruck 2007-03-31 due-trials
Other 2005-003484-23 Randomised phase-III-trial of simultaneous radiochemotherapy (RCT) of locally advanced head and neck cancer in the stages III and IV A-B: Comparing dose reduced RCT (63.6 Gy) with Paclitaxel/Cisplatin... not-yet-due
Not reported 2005-003854-80 Modulation of the Surgical Inflammatory Response by Etoricoxib: Peripheral versus Central 2010-12-15 due-trials
Not reported 2005-005434-12 Randomized, multicenter cross-over study investigating the effect of bicarbonate-based solutions (Physioneal 35 vs. 40) on protein metabolism in children and adolescents on chronic peritoneal dialysis 2012-05-15 due-trials
Ongoing 2005-005930-11 Einfach maskierte, randomisierte , cross over Studie zur Bestimmung der Wirkung von COSOPT® (Dorzolamid/ Timolol, MSD) auf die Perfusion und Sauerstoffsättigung der retinalen Gefäße bei Glaukompatient... not-yet-due
Not reported 2005-006151-20 Quetiapine and the dopaminergic epigenetic control – a pilot study 2008-07-08 due-trials
Ongoing 2006-002290-52 Telmisartan und systemische Inflammationsparameter bei Patienten mit arterieller Hypertonie und asymtomatischer Koronarer Herzkrankheit not-yet-due
Not reported 2006-002385-20 Prospective randomised multicenter phase-III-study: 2017-06-30 due-trials
Ongoing 2007-000390-31 Application of hypertonic hyperoncotic solutions for improvement of cardiac output after open heart surgery in children - monocentric, randomised, placebo controlled, double-blind clinical trial (phas... not-yet-due
Not reported 2007-000501-29 Low grade albuminuria: reaching a new target for irbesartan 2013-01-26 due-trials
Completed, but no date 2007-001166-33 A prospective, randomised, multicenter clinical trial investigating the reduction of Calcineurin inhibitor toxicity by means of steroid free long-term immune suppression with Ciclosporin A and Mycophe... bad-data
Ongoing 2007-007847-28 A multicenter, randomized, two-armed, open-label Phase III study to evaluate the adjuvant vaccination with tumor RNA-loaded autologous Dendritic Cells versus observation of patients with resected mono... not-yet-due
Not reported 2008-005365-61 A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH EROSIVE HAND OSTEOARTHRITIS 2013-07-19 due-trials
Not reported 2008-006268-12 Early treatment with deferasirox (Exjade®) in low risk MDS 2012-07-17 due-trials
Not reported 2008-008287-28 Effect of direct renin-inhibition aliskiren on renal haemodynamic and metabolic parameters in patients with prediabetes 2014-03-18 due-trials
Not reported 2009-009871-36 Effect and Safety of preventive Treatment with ACE-Inhibitor and Beta-Blocker on the onset of Left Ventricular Dysfunction in Duchenne Muscular Dystrophy 2016-01-18 due-trials
Ongoing 2009-010093-38 Multi-institutional Phase I/II Study: not-yet-due
Ongoing 2009-014476-21 Chemoradiation following induction chemotherapy in locally advanced, unresectable pancreatic cancer -a randomised phase 3 trial: not-yet-due
Ongoing 2009-014857-34 Intra-individual, randomized multicentric comparison of the MRI contrast agents Gadovist 1.0 versus Dotarem in patients with Multiple Sclerosis at 3T not-yet-due
Completed, report not yet due 2009-014895-23 Phase II clinical trial of a sequential therapy involving the FLOT regiment in palliative first-line treatment followed by AIO plus irinotecan in second-line treatment combined with supportive parente... 2018-04-30 not-yet-due
Ongoing 2009-015740-42 A PHASE 3, MULTICENTER, RANDOMIZED, OPEN, PROSPECTIVE, CONTROLLED, PARALLEL-GROUP STUDY OF REDUCTION OF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ONGOING REMISSION not-yet-due
Ongoing 2009-017676-24 Randomized, double blind, active-controlled, parallel study to analyse effects of the combination of aliskiren and valsartan on the vascular structure and function of retinal vessels not-yet-due
Ongoing 2010-018639-17 Prospective and open label study with blind end point evaluation on the effect of mineralcorticoid receptor inhibition on endothelial function of the micro- and macrovasculature in patient with metabo... not-yet-due
Not reported 2010-018979-16 EFFECTS OF SAXAGLITPIN ON ENDOTHELIAL FUNCTION IN PATIENTS WITH TYPE 2 DIABETES 2012-04-04 due-trials
Not reported 2010-019110-24 A PHASE 2, SINGLE-CENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF ZOLEDRONATE IN SUBJECTS WITH EROSIVE HAND OSTEOARTHRITIS 2013-12-18 due-trials
Ongoing 2010-022791-31 Contrast sensitivity of patients with normal tension glaucoma by application of Azarga® not-yet-due
Not reported 2011-003648-31 Pharmacokinetic-pharmacodynamic modeling of the postoperative pain sensation during patient-controlled analgesia with target-controlled infusion of Hydromorphone, taking into account the interaction w... 2012-09-10 due-trials
Completed, but no date 2012-001582-33 Intraindividual cross-over comparison of Gadobutrol and Gadoterate enhanced combined DSC-MR-Perfusion and MR-Angiography in patients with cerebrovascular disease bad-data
Not reported 2012-001583-29 Prospective, open-label, two-arm, parallel-group, single center phase IV clinical trial to evaluate the diagnostic value of a Gadobutrol enhanced dynamic susceptibility perfusion MRI (DSC-MRP) and a n... 2016-01-12 due-trials
Not reported 2012-002278-30 Effects of Linagliptin on Renal Endothelium Function in Patients with Type 2 Diabetes. 2014-02-06 due-trials
Listed as ongoing, but also has a completion date 2012-002944-25 EuroHYP-1: European multicentre, randomised, phase III clinical trial of therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke. 2018-05-09 bad-data
Completed, report not yet due 2012-003033-42 Prospective, open-label, multicentre clinical trial, phase I/IIa, to investigate the safety and tolerability of allogeneic B-cell concentrates CD3+-depleted, CD19+-enriched, cryopreserved (single admi... 2018-03-21 not-yet-due
Ongoing 2012-004240-30 Prospective, open-label, randomised, two-arm, controlled, multicentre clinical trial, phase I/IIa, for the evaluation of safety and efficacy of an adoptive immunotherapy with allogeneic CMV-/EBV-speci... not-yet-due
Ongoing 2013-000337-13 Prediction of response to Certolizumab Pegol treatment by functional MRI of the brain. A multi-center, randomized double-blind controlled study not-yet-due
Not reported 2013-004169-14 Randomized, placebo controlled, crossover clinical study to analyse the effect of dapagliflozin on microvascular and macrovascular circulation and total body sodium content 2015-10-02 due-trials
Ongoing 2014-000555-93 Abatacept reversing subclinical Inflammation as measured by MRI in ACPA positive Arthralgia not-yet-due
Ongoing 2014-001594-14 Prospective, single-centre, open-label, one-arm clinical trial, phase I/IIa, to assess the safety and tolerability and to investigate the predictive power of FITC-Adalimumab, when topically applied tw... not-yet-due
Ongoing 2014-003582-24 A double blind, randomised, multicentre, active controlled, parallel-group, phase III trial to evaluate the efficacy, safety and pharmacokinetics of intravenous clonidine (hydrochloride) compared to m... not-yet-due
Not reported 2014-004088-19 Postoperative pain treatment after elective cardiac surgery using patient-controlled target-controlled infusion (TCI-PCA) with hydromorphone vs. patient-controlled analgesia (PCA) with morphine 2016-12-01 due-trials
Not reported 2014-004798-17 Evaluation of inflammatory and structural joint damage in patients with psoriasis and psoriatic arthritis treated with secukinumab: A phase 2, single arm, single centre mode of action study (Psoriasis... 2017-09-18 due-trials
Ongoing 2015-000268-32 Prospective, open-label, randomised, single-centre, two-arm, parallel-group, cross-over controlled clinical study, phase 4, to investigate the efficacy of tropicamid 0.5% eyedrops compared to cyclopen... not-yet-due
Ongoing 2015-004184-36 Prospective, randomised, double-blind, placebo-controlled, single centre phase IIa clinical trial to investigate the safety and tolerability as well as the impact of a substitution of sexual hormones ... not-yet-due
Ongoing 2017-002122-20 Randomized phase II study of immune stimulation with Pembrolizumab and radiotherapy in second line therapy of metastatic head and neck squamous cell carcinoma (IMPORTANCE) not-yet-due
Ongoing 2017-002490-19 Prospective single-centre randomized observer-blind placebo-controlled parallel-group phase IIa clinical trial to investigate the safety and efficacy of ripasudil 0.4% eye drops after descemetorhexis ... not-yet-due
Ongoing 2017-002793-39 Abatacept Bone Effects in Psoriatic Arthritis with Bone Biomarker – ABEPSA_BB not-yet-due
Ongoing 2017-003226-33 First-line treatment of locally advanced HNSCC with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+ T cell infiltration (CheckRad-CD8) not-yet-due
Ongoing 2017-004129-33 Randomized, double-blind, placebo controlled, parallel-group, prospective clinical study to analyse the effect of evolocumab on vascular function. not-yet-due